Why Celestica Stock Jumped Today

Celestica shares rose more than 12% Tuesday after Q3 revenue increased 83% year over year to $5.8 billion and adjusted EPS rose 109% to $3.30. The company raised full-year guidance to $21 billion in revenue and $11.55 adjusted EPS, from $20.5 billion and $11.30, and forecast 2027 revenue of $40 billion and adjusted EPS of $21.50. Management cited robust AI-infrastructure demand and said customer forecasts for 2028 were meaningfully higher.

Analysis

The key debate is whether Celestica’s forecast embeds durable share gains or a concentrated customer buildout that can shift quickly. Margin expansion alongside volume supports operating leverage, but it does not establish that the step-up in 2027 revenue converts to comparable cash generation: verify customer concentration, working-capital needs, capex, and whether demand forecasts are backed by orders. If hyperscalers’ AI budgets remain firm, Celestica can benefit from continued outsourcing of complex systems; Jabil and Flex may also see demand, but the article provides no evidence that Celestica is taking share from them. Near term, the sharp repricing raises the hurdle for further upside. Over 1–3 months, hyperscaler capex commentary, order conversion, and any revisions to the 2027 outlook are the main catalysts. Over 6–18 months, deployment delays, power constraints, customer concentration, or pricing pressure could turn a high-growth ramp into volatile, lower-quality revenue. Contrarian risk: investors may be treating customer demand forecasts as committed shipments. The thesis weakens materially if guidance is cut, cash conversion deteriorates as growth accelerates, or adjusted operating margin falls below the recent 8.5% level without a temporary, explained cause.

Key Decisions for Investors

• Do not chase the immediate gap higher. For investors seeking exposure, consider scaling into TSX:CLS on a 5–8% pullback from the post-news closing price; that is an entry discipline, not a valuation target. Keep sizing moderate given customer and execution concentration.
• Treat the 2027 outlook as a catalyst to verify, not a de-risking event. Track quarterly order conversion, customer concentration, receivables/inventory, operating cash flow, and capex; these determine whether reported growth is translating into cash.
• Falsify the long thesis on a cut to the 2027 outlook, evidence of customer deferrals, or sustained adjusted-margin slippage below 8.5%. Reassess rather than average down if those signals appear.
• No clean competitor pair is established by this news: monitor Jabil and Flex for relative growth and margin evidence before positioning against them. Their exposure to the same AI infrastructure cycle could make a short-leg hedge blunt rather than protective.